【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 CRISPR and Cas Genes Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Rising adoption in diverse fields of biotechnology
3.1.1.1.1 Epigenetics
3.1.1.1.2 Medicine
3.1.1.1.3 Human germline editing
3.1.1.1.4 Tool for qualitative and quantitative plant genome editing
3.1.1.2 Technological advancements in CRISPR technology
3.1.1.3 Introduction of anti-CRISPR protein
3.1.1.4 Ongoing competition for CRISPR commercialization
3.1.2 Market Restraint Analysis
3.1.2.1 Off-target effects of CRISPR technology
3.1.2.2 Intellectual property disputes pertaining to Cas
3.1.2.3 Ethical concerns and implications with respect to human genome editing
3.2 Penetration & Growth Prospect Mapping for Application, 2015
3.3 CRISPR and Cas Genes -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
3.5 CRISPR and Cas Genes Market: Pipeline Analysis
3.5.1 Editas Medicine
3.5.2 Intellia Therapeutics, Inc.
3.5.3 CRISPR THERAPEUTICS
3.5.4 Precision Biosciences
3.5.5 Caribou Biosciences
3.5.6 Cibus
3.5.7 Recombinetics, Inc
3.6 CRISPR and Cas Genes Market: Patent Landscape
Chapter 4 CRISPR and Cas Genes Market: Product Estimates & Trend Analysis
4.1 CRISPR and Cas Genes Market: Product Movement Analysis
4.2 Vector-based Cas
4.2.1 Global vector-based Cas market, 2014 – 2025 (USD Million)
4.3 DNA-free Cas
4.3.1 Global DNA-free Cas market, 2014 – 2025 (USD Million)
Chapter 5 CRISPR and Cas Genes Market: Application Estimates & Trend Analysis
5.1 CRISPR and Cas Genes Market: Application Movement Analysis
5.2 Genome Engineering
5.2.1 Global genome engineering market, 2014 – 2025 (USD Million)
5.3 Disease Models
5.3.1 Global disease models market, 2014 – 2025 (USD Million)
5.4 Functional Genomics
5.4.1 Global functional genomics market, 2014 – 2025 (USD Million)
5.5 Knockdown/Activation
5.5.1 Global knockdown/activation market, 2014 – 2025 (USD Million)
5.6 Others
5.6.1 Global other applications market, 2014 – 2025 (USD Million)
Chapter 6 CRISPR and Cas Genes Market: End-use Estimates & Trend Analysis
6.1 CRISPR and Cas Genes Market: End-use Movement Analysis
6.2 Biotechnology & Pharmaceutical Companies
6.2.1 Global biotechnology & pharmaceutical companies market, 2014 – 2025 (USD Million)
6.3 Academic & Government Research Institutes
6.3.1 Global academic & government research institutes market, 2014 – 2025 (USD Million)
6.4 Contract Research Organizations (CROs)
6.4.1 Global CROs market, 2014 – 2025 (USD Million)
Chapter 7 CRISPR and Cas Genes Market: Regional Estimates & Trend Analysis, by Product, Application, & End-use
7.1 CRISPR and Cas Genes Market Share By Region, 2015 & 2025
7.2 North America
7.2.1 North America CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.3 Europe
7.3.1 Europe CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Germany CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.3.3 UK
7.3.3.1 UK CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.4.3 China
7.4.3.1 China CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Middle East & Africa CRISPR and Cas genes market, 2014 – 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa CRISPR and Cas genes market, 2014 – 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Addgene
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 AstraZeneca
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 Bio-Rad Laboratories, Inc
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Caribou Biosciences, Inc
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Cellectis
8.3.5.1 Company overview
8.3.5.1.1 Calyxt
8.3.5.2 Financial performance
8.3.5.2.1 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Cibus
8.3.6.1 Company overview
8.3.6.1.1 Nucelis
8.3.6.2 Financial performance
8.3.6.2.1 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 CRISPR THERAPEUTICS
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Editas Medicine
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Egenesis Inc.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.10 GE Healthcare Dharmacon Inc.
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 GenScript
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 Horizon Discovery Group plc
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives
8.3.13 Integrated DNA Technologies, Inc.
8.3.13.1 Company overview
8.3.13.2 Financial performance
8.3.13.3 Product benchmarking
8.3.14 Intellia Therapeutics, Inc.
8.3.14.1 Company overview
8.3.14.2 Financial performance
8.3.14.3 Product benchmarking
8.3.14.4 Strategic initiatives
8.3.15 Lonza
8.3.15.1 Company overview
8.3.15.2 Financial performance
8.3.15.3 Product benchmarking
8.3.15.4 Strategic initiatives
8.3.16 Merck KGaA
8.3.16.1 Company overview
8.3.16.1.1 Sigma-Aldrich Co. LLC
8.3.16.2 Financial performance
8.3.16.2.1 Financial performance
8.3.16.3 Product benchmarking
8.3.16.4 Strategic initiatives
8.3.17 Mirus Bio LLC
8.3.17.1 Company overview
8.3.17.2 Financial performance
8.3.17.3 Product benchmarking
8.3.17.4 Strategic initiatives
8.3.18 New England Biolabs
8.3.18.1 Company overview
8.3.18.2 Financial performance
8.3.18.3 Product benchmarking
8.3.18.4 Strategic initiatives
8.3.19 OriGene Technologies, Inc.
8.3.19.1 Company overview
8.3.19.2 Financial performance
8.3.19.3 Product benchmarking
8.3.19.4 Strategic initiatives
8.3.20 Recombinetics, Inc.
8.3.20.1 Company overview
8.3.20.2 Financial performance
8.3.20.3 Product benchmarking
8.3.20.4 Strategic initiatives
8.3.21 Takara Bio USA
8.3.21.1 Company overview
8.3.21.2 Financial performance
8.3.21.3 Product benchmarking
8.3.21.4 Strategic initiatives
8.3.22 Thermo Fisher Scientific, Inc.
8.3.22.1 Company overview
8.3.22.2 Financial performance
8.3.22.3 Product benchmarking
8.3.22.4 Strategic initiatives
8.3.23 Transposagen Biopharmaceuticals, Inc.
8.3.23.1 Company overview
8.3.23.2 Financial performance
8.3.23.3 Product benchmarking
8.3.23.4 Strategic initiatives
【レポート販売概要】
■ タイトル：CRISPRおよびCRISPR関連（Cas）遺伝子の世界市場分析：製品別（ベクター系…DNAフリーCas）、用途別（ゲノム工学、病気モデル、機能ゲノミクス）、エンドユーザー別、セグメント予測、2014-2025■ 英文：CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use, And Segment Forecasts, 2014-2025
■ 発行日：2017年1月31日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707227
■ 調査対象地域：グローバル
- Warren Resources, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Warren Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Warren Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- ポリフタラミドの世界市場：種類、用途、地域別市場分析With the heat resistant and low moisture absorption properties, polyphthalamide is popularly recognized as high performance polyamide and is ideal for use in a chemical environment or temperature extreme conditions. Common applications include automotive motor bobbin parts, fuel line connectors and coolant pumps as well as bushings and bearing pads in aircraft engines. The report analyzes the poly …
- 伐採機の世界市場About Tree TrimmerGarden tools such as tree trimmers are used to maintain healthy gardens and lawns. Currently, innovations like battery-powered tree trimmers that are lightweight and convenient to use are becoming increasingly popular. The key vendors in the market are increasingly focusing on improving the efficiency and functionality of the units to improve customer satisfaction and ease of usa …
- アナトーの世界市場2018-2022About Annatto Annatto is an orange-red condiment and food coloring derived from the seeds of the achiote tree (Bixa orellana). It is often used to impart a yellow or orange color to foods, but sometimes also used for its flavor and aroma. Apart from food and beverage, annatto extracts and seeds also find applications in the textile, cosmetics, and pharmaceutical industries. Technavio’s analysts fo …
- 世界の酸化亜鉛ナノ粒子市場The market for zinc oxide (ZnO) nanoparticles continues to grow, driven mainly by increasing demand for high SPF cosmetics and sunscreens. It acts as a transparent UV absorber offering long-term, broad band protection (UVA and UVB). ZnO nanoparticles are also being used for their anti-bacterial, anti-fungal, anti-corrosion and catalytic properties in industries such as textiles, paints and coating …
- 肺炎ワクチンの世界市場：ワクチン種類別（肺炎球菌複合ワクチン、肺炎球菌多糖ワクチン）、製品種類別（Prevnar 13、Synflorix、Pneumovax 23）、セクター別（公共、民間）、流通チャンネル別（流通パートナー企業、非政府組織・政府当局）The global pneumonia vaccines market was valued at $7,083 million in 2017 and is expected to reach $10,215 million by 2025, growing at a CAGR of 5% from 2018 to 2025. Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Pneumonia results in inflammation in the air sacs (kn …
- 世界のC型肝炎治療薬市場（2014-2018）About Hepatitis C Hepatitis C is a liver disease caused by infection due to hepatitis C virus. Hepatitis C infection predominantly affects the liver; however, other parts of the body are also affected such as the brain and the digestive system. Hepatitis C virus is an RNA virus belonging to the family Flaviviridae and genus hepacivirus. It has a positive-sense, single-stranded RNA molecule envelop …
- 世界のPrepared Meals市場：M&A動向（2014年4月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global prepared meals market during April 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global prepared meals market throughout the month. Additionally, the report provides an overview of all …
- マーケティング技術の世界市場2015-2019About Global Marketing Technology Market Organizations are changing their approach toward marketing influenced by the development of new sales channels, website traffic management, and branding. Marketing is mapped now with the expectation of lead generation. With budget constraints, organizations are focusing on connecting generated leads with marketing campaigns throughout the sales process and …
- 歯科用レーザーの世界市場予測（～2020）In this report, the global dental laser market has been analyzed and segmented based on product, application, end user, and region. The report analyses competitive developments, such as alliance, joint venture, and merger & acquisition in the market. This market has also been analyzed with an explicit focus on the high-growth applications and fastest-growing market segments. Dental lasers are used …
- 世界のLTE市場及びMBBスペクトルThe bundle World LTE market & MBB spectrum includes two deliverables dealing with both LTE and spectrum issues: 1. A database (updated half-yearly): quantitative & qualitative data for 45 countries, 6 zones & world consolidated - 76 LTE operator sheets are also available. It gathers information about spectrum issues, technologies, revenue & subscriber data & forecasts up to 2019. It presents the c …
- プロフェッショナルデンタルケアの世界市場予測（～2021年）The global professional dental care market is valued at USD 769.3 million in 2016 and is estimated to reach USD 961.0 million by 2021, with a CAGR of 4.5% during the forecast period of 2016-2021. The growth of this market is mainly attributed to the growing number of small/private dental clinics, rising incidences of dental caries, increasing disposable incomes in emerging countries, growing aware …
- 脳橋神経膠腫：世界の臨床試験レビュー（2014年上半期）Pontine Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Pontine Glioma Global Clinical Trials Review, H1, 2014" provides data on the Pontine Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pontine Glioma. It includes an overview of the trial numbers and their recruitment status as per …
- 電気自動車（EV）用パワーインバーターの世界市場2017-2021About Electric Vehicle Power InverterA power inverter or inverter is an electric device that converts DC (direct current) to AC (alternating current). It is an assembly of power devices and passive components. The power devices, also called IGBT (insulated-gate bipolar transistor) stack, are built with IGBTs and passive components. IGBTs are made from Si (silicon) material components. The passive …
- 世界の腸疾患テスト市場動向（2014-2018）TechNavio's analysts forecast the Global Enteric Disease Testing market to grow at a CAGR of 2.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of enteric diseases. The Global Enteric Disease Testing market has also been witnessing the emergence of new pathogens causing infections. However, the stringent regulatory approval …
